Wenjun Cheng

3.4k total citations · 1 hit paper
76 papers, 2.4k citations indexed

About

Wenjun Cheng is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, Wenjun Cheng has authored 76 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 24 papers in Cancer Research and 15 papers in Reproductive Medicine. Recurrent topics in Wenjun Cheng's work include Cancer-related molecular mechanisms research (19 papers), Ovarian cancer diagnosis and treatment (14 papers) and Circular RNAs in diseases (11 papers). Wenjun Cheng is often cited by papers focused on Cancer-related molecular mechanisms research (19 papers), Ovarian cancer diagnosis and treatment (14 papers) and Circular RNAs in diseases (11 papers). Wenjun Cheng collaborates with scholars based in China, United States and Hong Kong. Wenjun Cheng's co-authors include Honami Naora, Jinsong Liu, Yicong Wan, Lin Zhang, Daniel Rosen, Yi Jiang, Yi Liu, Denise J. Montell, Jinhui Liu and Yi Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Wenjun Cheng

70 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment

2023 304 citations Yicong Wan, Lin Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wenjun Cheng China	22	1.2k	769	376	359	282	76	2.4k
Ying Zhu China	34	1.5k 1.2×	897 1.2×	754 2.0×	379 1.1×	131 0.5×	145	3.4k
Paweł Włodarski Poland	32	1.4k 1.1×	468 0.6×	671 1.8×	245 0.7×	96 0.3×	193	3.2k
Jean Lu Taiwan	30	1.1k 0.9×	408 0.5×	838 2.2×	99 0.3×	266 0.9×	59	2.3k
Thai‐Yen Ling Taiwan	22	717 0.6×	262 0.3×	187 0.5×	204 0.6×	131 0.5×	52	1.8k
Caiyun Zhou China	24	823 0.7×	410 0.5×	272 0.7×	112 0.3×	348 1.2×	71	1.6k
Zhiwei Hu United States	27	661 0.5×	275 0.4×	635 1.7×	303 0.8×	111 0.4×	66	2.2k
Tokuhiro Chano Japan	31	1.4k 1.1×	542 0.7×	498 1.3×	403 1.1×	65 0.2×	108	2.7k
Kelly A. Whelan United States	30	1.6k 1.3×	439 0.6×	545 1.4×	190 0.5×	251 0.9×	63	2.9k
Hikaru Sonoda Japan	21	2.4k 1.9×	1.2k 1.6×	387 1.0×	219 0.6×	36 0.1×	37	2.9k

Countries citing papers authored by Wenjun Cheng

Since Specialization

Citations

This map shows the geographic impact of Wenjun Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjun Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjun Cheng more than expected).

Fields of papers citing papers by Wenjun Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjun Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjun Cheng. The network helps show where Wenjun Cheng may publish in the future.

Co-authorship network of co-authors of Wenjun Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjun Cheng. A scholar is included among the top collaborators of Wenjun Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjun Cheng. Wenjun Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Benyan, et al.. (2025). Precision aerosol-jet micropatterning of liquid metal for high-performance flexible strain sensors. Nature Communications. 16(1). 7920–7920. 3 indexed citations

Lin, Changqing, et al.. (2025). Controlling surface energy of CsPbBr3 QDs via ligand engineering to mitigate coffee ring effect for flexible display application. Colloids and Surfaces A Physicochemical and Engineering Aspects. 726. 137834–137834.

Chen, Tian, Shulin Zhou, Huangyang Meng, et al.. (2025). Overcoming Ferroptosis-Induced Exhaustion of NK Cells through Inhibition of the ATF3-Mediated Integrated Stress Response in Ovarian Cancer. International Journal of Biological Sciences. 21(12). 5531–5546.

Zhang, Hao, et al.. (2024). Engineering bioinspired rigid-soft architecture for enhanced stiffness and toughness in liquid-free stretchable ionic conductors. Chemical Engineering Journal. 497. 154605–154605. 3 indexed citations

Zhang, Lin, et al.. (2024). Derivation and validation of a nomogram based on clinical characteristics to diagnose endometriosis associated ovarian cancer preoperatively. Journal of Cancer Research and Clinical Oncology. 150(1). 19–19. 1 indexed citations

Cao, Yuwei, Yao Lu, Jiacheng Song, et al.. (2024). Time-dependent diffusion MRI-based microstructural mapping for differentiating high-grade serous ovarian cancer from serous borderline ovarian tumor. European Journal of Radiology. 178. 111622–111622. 7 indexed citations

Shen, Yuanming, Beihua Kong, Bairong Xia, et al.. (2023). Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial.. Journal of Clinical Oncology. 41(16_suppl). 5556–5556. 1 indexed citations

Wan, Yicong, et al.. (2022). Bractoppin, a BRCA1 carboxy-terminal domain (BRCT) inhibitor, suppresses tumor progression in ovarian borderline tumor organoids. Biochemical and Biophysical Research Communications. 638. 76–83. 6 indexed citations

Liu, Jinhui, Jing Yang, Feng Gao, et al.. (2020). A microRNA–Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer. DNA and Cell Biology. 39(7). 1328–1346. 11 indexed citations

10.

Liu, Jinhui, Sipei Nie, Siyue Li, et al.. (2020). Methylation-driven genes and their prognostic value in cervical squamous cell carcinoma. Annals of Translational Medicine. 8(14). 868–868. 20 indexed citations

11.

Liu, Jinhui, Xing Chen, Yi Jiang, & Wenjun Cheng. (2020). Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer. International Immunopharmacology. 86. 106735–106735. 21 indexed citations

12.

Zhang, Lin, Yicong Wan, Yi Jiang, et al.. (2019). Overexpression of BP1, an isoform of Homeobox Gene DLX4, promotes cell proliferation, migration and predicts poor prognosis in endometrial cancer. Gene. 707. 216–223. 18 indexed citations

13.

Cheng, Wenjun, et al.. (2018). Boron-doped graphene as a metal-free catalyst for gas-phase oxidation of benzyl alcohol to benzaldehyde. RSC Advances. 8(20). 11222–11229. 26 indexed citations

14.

Yang, Yijun, Yi Jiang, Yicong Wan, et al.. (2016). UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis. Tumor Biology. 37(8). 10633–10641. 78 indexed citations

15.

Jiang, Yi, Fangrong Yan, Liang Li, et al.. (2016). Meta-analysis demonstrates no association between p16 ink4a promoter methylation and epithelial ovarian cancer. Archives of Gynecology and Obstetrics. 295(3). 697–704. 5 indexed citations

16.

Shi, Li, Shulin Zhou, Yi Jiang, et al.. (2014). [Gynecological malignant tumor related multiple primary malignant neoplasms: clinical analysis of 30 cases].. PubMed. 49(3). 199–203. 2 indexed citations

17.

Chen, Xiaoxiang, Jing Zhang, Zhihong Zhang, et al.. (2013). Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma. Human Pathology. 44(11). 2373–2384. 53 indexed citations

18.

Xu, Shaohua, Wei Wu, Hong Sun, et al.. (2012). Association of the Vascular Endothelial Growth Factor Gene Polymorphisms (–460C/T, +405G/C and +936T/C) with Endometriosis: A Meta‐Analysis. Annals of Human Genetics. 76(6). 464–471. 16 indexed citations

19.

Bi, Long, Wenjun Cheng, Hongbin Fan, & Guoxian Pei. (2010). Reconstruction of goat tibial defects using an injectable tricalcium phosphate/chitosan in combination with autologous platelet-rich plasma. Biomaterials. 31(12). 3201–3211. 100 indexed citations

20.

Silver, Debra L., Honami Naora, Jinsong Liu, Wenjun Cheng, & Denise J. Montell. (2004). Activated Signal Transducer and Activator of Transcription (STAT) 3. Cancer Research. 64(10). 3550–3558. 221 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact